A. M. M. Eggermont

Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population‐based series

Anne E. M. van der Pool, Ronald Damhuis, Jan N.M. IJzermans et al. · Colorectal Disease · 2010 · 259 citations

Medicine, Oncology, Surgery +17

Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells.

A. M. M. Eggermont, E P Steller, Paul H. Sugarbaker · PubMed · 1987 · 218 citations

Life Sciences, Immunology, Oncology +13

Harly endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high‐dose tumour necrosis factor alpha (rTNFα)

Nathalie Renard, D. Liénard, Laurence Lespagnard et al. · International Journal of Cancer · 1994 · 143 citations

Veterinary Medicine, Immunology, Oncology +17

Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.

Joost M. Klaase, B.B.R. Kroon, A N van Geel et al. · PubMed · 1994 · 104 citations

Medicine, Oncology, Surgery +17

Synergistic effects of TNF-α and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study

PTGA Nooijen, ER Manusama, A. M. M. Eggermont et al. · British Journal of Cancer · 1996 · 86 citations · Full text

Medicine, Oncology, Pharmacology +15